Quality management systems — applying good distribution practices to the biopharmaceutical supply chain

AdobeStock_214876031 (2)

Source: Adobe Stock

It is important to ensure compliance with good distribution practice (GDP) throughout the product lifecycle. Failure to incorporate GDP at both pre-and post-market stage may have regulatory implications.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

Not a TOPRA member yet? 

Join now to get access to:

  • Features and specialist articles
  • CPD supplements
  • Comprehensive archive

Not sure yet?  Read one of our free editorials to see what you’re missing out on!